Correction to: Adv Ther https://doi.org/10.1007/s12325-020-01376-0
In the original article, the incorrect funding statement has been published. The correct funding statement is "This study is supported by the national key R&D project (contract no. 2016YFC1301303, 2016YFC1301300) and an investigator-initiated grant by AstraZenca Co. Ltd. No funding was received for the journals rapid service fee".
About this article
Cite this article
Ma, S., Jiang, Z., Qiu, M. et al. Correction to: Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study. Adv Ther 37, 3162 (2020). https://doi.org/10.1007/s12325-020-01401-2